Ken Fisher acquired 12.6 Million Novo Nordisk shares worth $831 Million. That's 0.34% of their equity portfolio (73rd largest holding). The first Novo Nordisk trade was made in Q1 2013. Since then Ken Fisher bought shares 22 more times and sold shares on 25 occasions. The stake costed the investor $555 Million, netting the investor a gain of 50% so far.